Ieso Launches Clinical Research Trial to Treat Comorbid Depression and Anxiety in Patients with Type 2 Diabetes
2019 Dec 11
Ieso to treat approximately 500 patients with tailored, online cognitive behavioural therapy to measure the effects of treatment
Ieso Digital Health, a leader in internet-enabled cognitive behavioural therapy (ie-CBT), today announced its clinical trial to measure the effects of online, diabetes-focused CBT intervention on the mental health outcomes of patients with type 2 diabetes. Studies have found that mental health issues amongst those diagnosed with diabetes are far greater than for those without diabetes, with 25% reported to live with depression and 40% with anxiety . This study will help Ieso understand more about whether treating a mental health condition in the context of diabetes has a positive impact on mental wellbeing and subsequently diabetes management for patients.
As an IAPT (Increasing Access to Psychological Therapies) programme service, Ieso provides ie-CBT to 74 NHS Clinical Commissioning Groups across England and Scotland today, and has treated 50,000 patients through its ThinkWell platform. Many of those referred for treatment have lived with the additional complexity of long-term conditions including diabetes. However, there is a shortage of therapists that provide tailored treatment for these patients with comorbid depression or anxiety.
Ieso’s affiliate BABCP therapists involved in the type 2 diabetes trial have followed a rigorous training programme designed to help them adapt CBT to provide more specialist care, while also understanding more about the condition from a patient and clinical perspective. The aim of Ieso’s trial is to ascertain the effects of ie-CBT on two measurable outcomes (using GAD7 and PHQ9). Firstly, does the patient feel less anxious or depressed following a course of treatment and secondly, do they feel less stressed by their diabetes?
Sarah Bateup, Chief Clinical Officer at Ieso Digital Health, commented: “We have found through our extensive experience in treating mental health conditions with CBT, that there is a prevalence of stress, depression and anxiety amongst patients that have also been diagnosed with a long-term, physical condition, such as type 2 diabetes. Although all of our therapists receive thorough training to understand all elements of mental health, it is much more difficult to adapt to patients specific needs unless they know more about the condition and how to adapt in the best way.
“Rather than simply extend our service with a tailored treatment, we felt it imperative to run a clinical trial first to test the training and understand the treatment benefits patients can expect before offering a full service to our NHS partners.”
To be eligible for the clinical study, participants will need to live in England, be over 18 and have been diagnosed with type 2 diabetes for at least 12 months. Once selected, participants will be assessed before receiving a course of online CBT therapy with their allocated therapist. There is no set length of time for treatment but Ieso expects patients to receive between 4 and 12 sessions. Participants will be assessed at the end of treatment and again six months after the study has concluded, to check whether the effects are maintained.
Ieso is working with GPs to locate patients and more information about the study and how to apply can be found at: https://www.iesohealth.com/en-gb/online-cbt/cbt4diabetes. This research is conducted with support from Roche Diabetes Care Limited.